Cargando…
ANXA6: a key molecular player in cancer progression and drug resistance
Annexin-A6 (ANXA6), a Ca(2+)-dependent membrane binding protein, is the largest of all conserved annexin families and highly expressed in the plasma membrane and endosomal compartments. As a multifunctional scaffold protein, ANXA6 can interact with phospholipid membranes and various signaling protei...
Autores principales: | Cao, Jinlong, Wan, Shun, Chen, Siyu, Yang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154440/ https://www.ncbi.nlm.nih.gov/pubmed/37129645 http://dx.doi.org/10.1007/s12672-023-00662-x |
Ejemplares similares
-
FADD as a key molecular player in cancer progression
por: Liu, Ying, et al.
Publicado: (2022) -
Epigenetic modifications: Key players in cancer heterogeneity and drug resistance
por: Sadida, Hana Q., et al.
Publicado: (2023) -
ANXA6 suppresses the tumorigenesis of cervical cancer through autophagy induction
por: Sun, Xin, et al.
Publicado: (2020) -
Sphingolipids: Key Regulators of Apoptosis and Pivotal Players in Cancer Drug Resistance
por: Giussani, Paola, et al.
Publicado: (2014) -
Blood Vessels and Peripheral Nerves as Key Players in Cancer Progression and Therapy Resistance
por: Roda, Niccolò, et al.
Publicado: (2021)